NEXI logo

NEXINeximmune Inc

$0.0001
$0.00
(0.00%)
Today
Updated: 09:31 AM EDT
Mkt Cap$139.00
Vol3.00

About

NexImmune, Inc. is a clinical stage biotechnology company, which engages in the development of novel approach to immunotherapy designed to employ the body's own T cells to generate an antigen-specific cell-mediated immune response with curative potential for the patient. Its product candidates are NEXI-001 in acute myeloid leukemia, or AML, and NEXI-002 in multiple myeloma, or MM. The company was founded by Kenneth C. Carter, Jonathan Schneck, and Mathias Oelke on June 7, 2011 and is headquartered in Gaithersburg, MD.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Neximmune Inc?
What is the 52-week high for Neximmune Inc?
What is Neximmune Inc stock price today?
What was Neximmune Inc stock price yesterday?
What is the 50-day moving average of Neximmune Inc?

Advertisement|Remove ads.